Systematic Review of Results of Kissing Stents in the Treatment of Aortoiliac Occlusive Disease

Jebbink, Erik Groot; Holewijn, Suzanne; Slump, Cornelis H.; Lardenoije, Jan-Willem; Reijnen, Michel M.P.J.

doi:10.1016/j.avsg.2017.01.009

Cited by 40 publications

(37 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In a recent review, it was shown that the indications for treatment with kissing stents varied greatly, from 33% to 100% of patients treated for claudication. 20 In the present study 36.9% of the patients were treated for critical limb ischemia. In addition, the incidence of TASC A and B lesions treated with kissing stents varied from 0% to 92%, rendering comparisons unfair with the present group of patients, who were mostly treated for TASC-II D lesions.…”

Section: Discussionmentioning

confidence: 71%

Editor's Choice – First Results of the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) Technique for Aortoiliac Occlusive Disease

Grimme

Goverde

Verbruggen

et al. 2015

European Journal of Vascular and Endovascular Surgery

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 71%

Editor's Choice – First Results of the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) Technique for Aortoiliac Occlusive Disease

Grimme

Goverde

Verbruggen

et al. 2015

European Journal of Vascular and Endovascular Surgery

View full text Add to dashboard Cite

show abstract

“…1,2 The long-term outcome, however, has not matched that of open surgery due to a high rate of reinterventions to assure stent patency. 3–6 Data published on the results of KS treatment usually include relatively low sample sizes (mean 63.2, range 18–215), 7 owing to the low prevalence of AIOD. Not only do these sample sizes hamper longer term analysis, but the heterogeneity of included patient groups reduces the comparability with respect to open surgery, though it does provide an opportunity for subgroup analysis.…”

Section: Introductionmentioning

confidence: 99%

Meta-analysis of Individual Patient Data After Kissing Stent Treatment for Aortoiliac Occlusive Disease

et al. 2018

Self Cite

View full text Add to dashboard Cite

Purpose: To evaluate short- and long-term technical and clinical outcomes after kissing stent treatment of aortoiliac occlusive disease (AIOD) based on an individual participant data (IPD) meta-analysis. Materials and Methods: A search of the Scopus database identified 156 articles on KS treatment of AIOD; of these 22 met the inclusion criteria. Authors of 19 articles with contact information were approached to join an IPD consortium. Eight author groups responded and 5 provided anonymized data for merging into an IPD database. The number of included procedures was equal before and after 2005. The primary study outcome was the cumulative patency at 24 months. Secondary outcomes were patency at up to 60 months, complications, and changes in Rutherford category and ankle-brachial index. The predictive value of stent protrusion length, pre-/postdilation, stent type, and patient demographics on primary patency were examined with Cox proportional hazard modeling; outcomes are reported as the hazard ratio (HR). The Kaplan-Meier method was employed to estimate patency rates. Results: In total, 605 (40.9%) of 1480 patients presented in the literature were included in the IPD analysis. The indication for intervention was intermittent claudication in 84.2% and critical limb ischemia in 15.8%. Lesions were classified as TransAtlantic Inter-Society Consensus (TASC) A or B in 52.8% and TASC C and D in 47.2%. The overall primary patency estimate was 81% at 24 months. Primary patency significantly increased after 2005 (p=0.005). Cox regression analysis revealed only age as a significant predictor of sustained primary patency (HR 0.60, p<0.005). Any previous endovascular intervention (HR 2.52, p=0.02) was the main predictor for loss of secondary patency; history of cardiovascular disease (HR 0.27, p=0.04) was the main predictor of sustained secondary patency. Conclusion: The kissing stent technique has a good safety profile and acceptable patency rates up to 2 years, even in TASC C and D lesions, supporting an endovascular-first approach for AIOD.

show abstract

“…Aortoiliac disease is a major cause of claudication and/or critical limb ischemia, with a prevalence up to 10% in the general population, increasing up to 20% in patients aged over 70 ( 1 ).…”

Section: Introductionmentioning

confidence: 99%

“…Nevertheless, OS is associated with higher per-surgical complications and mortality than the EV technique ( 1 ). Thus, several EV options have been developed to treat even high-grade lesions, especially in elderly and fragile patients.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Use of Re-entry Devices in Aortoiliac Occlusive Disease

Pescatori

Tacher

Kobeiter

2020

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

Endovascular approach is the first-choice treatment in patients suffering from aortoiliac occlusions. Nevertheless, standard endoluminal revascularization fails in treating occlusions in about 20% ( 1 ) of cases. Thus, subintimal revascularization can be a solution, but it fails in 25% ( 2 ) of cases as well. In the last decades, different devices have been created, in order to ease the cross back into the true lumen, when standard subintimal revascularization does not work or risks to occlude important collateral vessels. Herein, we revise the currently available re-entry devices and their application in the aortoiliac occlusive pathology.

show abstract

Systematic Review of Results of Kissing Stents in the Treatment of Aortoiliac Occlusive Disease

Cited by 40 publications

References 34 publications

Editor's Choice – First Results of the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) Technique for Aortoiliac Occlusive Disease

Editor's Choice – First Results of the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) Technique for Aortoiliac Occlusive Disease

Meta-analysis of Individual Patient Data After Kissing Stent Treatment for Aortoiliac Occlusive Disease

The Use of Re-entry Devices in Aortoiliac Occlusive Disease

Contact Info

Product

Resources

About